WTAP regulates Mitochondrial damage and Lipid oxidation in HCC by NOA1 mediated m6A modification
2025

WTAP's Role in Mitochondrial Damage and Lipid Oxidation in Liver Cancer

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): Liu Sheng, Shang Mei, Gong Jiao, Sun Hengchang, Hu Bo

Primary Institution: Third Affiliated Hospital of Sun Yat-sen University

Hypothesis

WTAP regulates mitochondrial damage and lipid oxidation in hepatocellular carcinoma (HCC) through NOA1 mediated m6A modification.

Conclusion

WTAP may affect the m6A methylation of NOA1 to induce mitochondrial damage and inhibit lipid oxidation, contributing to the development of HCC.

Supporting Evidence

  • WTAP expression was significantly decreased in tumor tissues compared to normal tissues.
  • Knockdown of WTAP induced mitochondrial damage in hepatoma cells.
  • WTAP knockdown increased GPX4 expression, indicating a role in ferroptosis regulation.
  • NOA1 levels were inversely related to WTAP expression in hepatoma cells.

Takeaway

This study found that a protein called WTAP helps control how another protein, NOA1, works in liver cancer, which affects how cells use energy and handle fats.

Methodology

The study used RT-PCR, Western blot, electron microscopy, and mass spectrometry to analyze the expression of m6A methylation-associated enzymes and their effects on mitochondrial function in hepatoma cells.

Limitations

The study was limited to a small sample size of 17 patients and focused on specific cell lines.

Participant Demographics

The study included 17 patients diagnosed with hepatocellular carcinoma, predominantly male (94.1%) with an average age of 57 years.

Statistical Information

P-Value

p=0.0011 for WTAP expression differences

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7150/jca.102618

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication